Granules India

{
  "main_header": {
    "sid": 580033,
    "name": "Granules India",
    "stock_name": "Granules India",
    "full_name": "Granules India Ltd",
    "name_url": "stocks-analysis/granules-india",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "570.65",
    "chg": 17.4,
    "chgp": "3.15%",
    "dir": 1,
    "prev_price": "553.25",
    "mcapval": "13,860.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 532482,
    "symbol": "GRANULES",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE101D01020",
    "curr_date": "Feb 03",
    "curr_time": "",
    "bse_nse_vol": "8.62 lacs",
    "exc_status": "Active",
    "traded_date": "Feb 03, 2026",
    "traded_date_str": "2026 02 03",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/granules-india-580033-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Granules India Ltd is Rated Hold by MarketsMOJO",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/granules-india-ltd-is-rated-hold-by-marketsmojo-3816377",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/GranulesIndiaLt_mojoScore_3816377.png",
        "date": "2026-02-02 10:10:04",
        "description": "Granules India Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 23 January 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 02 February 2026, providing investors with the most up-to-date view of the stock’s fundamentals, returns, and technical outlook."
      },
      {
        "title": "Granules India Ltd Reports Strong Quarterly Growth, Upgrades Financial Trend to Positive",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/granules-india-ltd-reports-strong-quarterly-growth-upgrades-financial-trend-to-positive-3804851",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/GranulesIndiaLt_fintrenddot_3804851.png",
        "date": "2026-01-27 08:00:16",
        "description": "Granules India Ltd has demonstrated a marked improvement in its financial performance for the quarter ended December 2025, prompting an upgrade in its financial trend from flat to positive. The pharmaceutical company posted record quarterly revenue and profitability metrics, signalling a potential turnaround after a period of subdued growth."
      },
      {
        "title": "Granules India Ltd Declines 2.86%: Technical Shifts and Mixed Signals Shape the Week",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/granules-india-ltd-declines-286-technical-shifts-and-mixed-signals-shape-the-week-3803602",
        "imagepath": "",
        "date": "2026-01-24 16:11:39",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>Jan 19:</strong> Stock opens at ₹573.95, declines 1.32% amid broader market weakness</p>\n                    <p><strong>Jan 20:</strong> Sharp fall of 3.70% to ₹552.70 following technical deterioration</p>\n                    <p><strong>Jan 21:</strong> Continued decline of 2.87% to ₹536.85 as bearish momentum builds</p>\n                    <p><strong>Jan 22:</strong> Strong rebound of 6.40% to ₹571.20 coinciding with downgrade announcement</p>\n                    <p><strong>Jan 23:</strong> Mild pullback of 1.09% to close the week at ₹564.95 amid mixed technical signals</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\">..."
      },
      {
        "title": "Are Granules India Ltd latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-granules-india-ltd-latest-results-good-or-bad-3802408",
        "imagepath": "",
        "date": "2026-01-23 19:13:51",
        "description": "Granules India Ltd reported its financial results for Q3 FY26, showcasing a robust operational performance. The company achieved net sales of ₹1,387.94 crores, reflecting a sequential growth of 7.01% from the previous quarter and a year-on-year increase of approximately 22.00%. This marks the seventh consecutive quarter where revenue has surpassed ₹1,100 crores, indicating a consistent scaling of operations.\n\nNet profit for the quarter reached ₹150.21 crores, which is a 15.01% increase compared to the prior quarter and a notable 34.33% rise year-on-year. The operating margin improved to 22.20%, the highest recorded in the last eight quarters, demonstrating enhanced operational efficiency and a favorable product mix. The profit after tax margin also strengthened, indicating the company's ability to convert revenue growth into profitability effectively.\n\nThe company’s balance sheet reflects a solid financial ..."
      },
      {
        "title": "Granules India Q3 FY26: Strong Momentum Continues with Record Quarterly Performance",
        "link": "https://www.marketsmojo.com/news/result-analysis/granules-india-q3-fy26-strong-momentum-continues-with-record-quarterly-performance-3802388",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/GranulesIndia_quaterlyResult_3802388.png",
        "date": "2026-01-23 18:01:03",
        "description": "Granules India Limited reported its strongest quarterly performance on record in Q3 FY26, with net profit surging to ₹150.21 crores, marking a robust 15.00% quarter-on-quarter growth and an impressive 34.33% year-on-year expansion. The Hyderabad-based pharmaceutical manufacturer, with a market capitalisation of ₹14,024 crores, demonstrated exceptional operational momentum across all business verticals despite navigating a challenging global pharmaceutical environment."
      },
      {
        "title": "Granules India Ltd Sees Technical Momentum Shift Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/granules-india-ltd-sees-technical-momentum-shift-amid-mixed-market-signals-3800981",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/GranulesIndiaLt_technicaldot_3800981.png",
        "date": "2026-01-23 08:01:05",
        "description": "Granules India Ltd has experienced a notable shift in its technical momentum, moving from a mildly bearish to a mildly bullish trend as of late January 2026. Despite a recent downgrade in its Mojo Grade from Hold to Sell, the stock’s price action and key technical indicators suggest a nuanced outlook for investors navigating the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Granules India Ltd Downgraded to Sell Amid Technical Weakness and Flat Financials",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/granules-india-ltd-downgraded-to-sell-amid-technical-weakness-and-flat-financials-3799585",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/GranulesIndiaLt_mojoScore_3799585.png",
        "date": "2026-01-22 08:05:29",
        "description": "Granules India Ltd, a key player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Hold to Sell as of 21 January 2026. This shift reflects a combination of deteriorating technical indicators, subdued financial trends, and valuation concerns, despite some strengths in management efficiency and debt servicing capability."
      },
      {
        "title": "Granules India Ltd Faces Technical Momentum Shift Amid Bearish Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/granules-india-ltd-faces-technical-momentum-shift-amid-bearish-signals-3799483",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/GranulesIndiaLt_technicaldot_3799483.png",
        "date": "2026-01-22 08:00:52",
        "description": "Granules India Ltd has experienced a notable shift in its technical momentum, moving from a mildly bullish to a mildly bearish trend as of late January 2026. This change is underscored by a downgrade in its MarketsMOJO grade from Hold to Sell, reflecting growing concerns among analysts about the stock’s near-term price trajectory amid mixed technical indicator signals."
      },
      {
        "title": "Why is Granules India Ltd falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-granules-india-ltd-fallingrising-3793112",
        "imagepath": "",
        "date": "2026-01-17 00:45:09",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Short-Term Price Movement and Market Performance</strong></p>\n<p>Granules India’s share price decline on 16-Jan was sharper than the broader market and its sector peers. The stock underperformed its sector by 1.86%, touching an intraday low of ₹576.80, representing a 3.77% drop during the trading session. The weighted average price indicates that a greater volume of shares traded closer to the day’s low, signalling selling pressure throughout the day. This price action suggests that investors were more inclined to offload shares rather than accumulate at higher levels.</p>\n<p>Further compounding the downward pressure was the stock’s position relative to its moving averages. While the price remains above the 50-day, 100-day, and 200-day moving averages—indicating a generally positive medium t..."
      }
    ],
    "total": 437,
    "sid": "580033",
    "stock_news_url": "https://www.marketsmojo.com/news/granules-india-580033"
  },
  "announcements": [
    {
      "caption": "Transcript For Earnings Conference Call For Q3 Of FY26",
      "datetime": "28-Jan-2026",
      "details": "Transcript for earnings conference call for Q3 of FY26",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
      "datetime": "23-Jan-2026",
      "details": "Audio Recording of the Earnings call for Q3 of FY26",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
      "datetime": "23-Jan-2026",
      "details": "Press Release",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Granules India Ltd has declared <strong>150%</strong> dividend, ex-date: 31 Jul 25",
          "dt": "2025-07-31",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Granules India Ltd has announced <strong>1:10</strong> stock split, ex-date: 23 Mar 15",
          "dt": "2015-03-23",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Granules India Ltd is Rated Hold by MarketsMOJO

2026-02-02 10:10:04

Granules India Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 23 January 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 02 February 2026, providing investors with the most up-to-date view of the stock’s fundamentals, returns, and technical outlook.

Read full news article

Granules India Ltd Reports Strong Quarterly Growth, Upgrades Financial Trend to Positive

2026-01-27 08:00:16

Granules India Ltd has demonstrated a marked improvement in its financial performance for the quarter ended December 2025, prompting an upgrade in its financial trend from flat to positive. The pharmaceutical company posted record quarterly revenue and profitability metrics, signalling a potential turnaround after a period of subdued growth.

Read full news article

Granules India Ltd Declines 2.86%: Technical Shifts and Mixed Signals Shape the Week

2026-01-24 16:11:39

Key Events This Week

Jan 19: Stock opens at ₹573.95, declines 1.32% amid broader market weakness

Jan 20: Sharp fall of 3.70% to ₹552.70 following technical deterioration

Jan 21: Continued decline of 2.87% to ₹536.85 as bearish momentum builds

Jan 22: Strong rebound of 6.40% to ₹571.20 coinciding with downgrade announcement

Jan 23: Mild pullback of 1.09% to close the week at ₹564.95 amid mixed technical signals

...

Read full news article

Are Granules India Ltd latest results good or bad?

2026-01-23 19:13:51

Granules India Ltd reported its financial results for Q3 FY26, showcasing a robust operational performance. The company achieved net sales of ₹1,387.94 crores, reflecting a sequential growth of 7.01% from the previous quarter and a year-on-year increase of approximately 22.00%. This marks the seventh consecutive quarter where revenue has surpassed ₹1,100 crores, indicating a consistent scaling of operations. Net profit for the quarter reached ₹150.21 crores, which is a 15.01% increase compared to the prior quarter and a notable 34.33% rise year-on-year. The operating margin improved to 22.20%, the highest recorded in the last eight quarters, demonstrating enhanced operational efficiency and a favorable product mix. The profit after tax margin also strengthened, indicating the company's ability to convert revenue growth into profitability effectively. The company’s balance sheet reflects a solid financial ...

Read full news article

Granules India Q3 FY26: Strong Momentum Continues with Record Quarterly Performance

2026-01-23 18:01:03

Granules India Limited reported its strongest quarterly performance on record in Q3 FY26, with net profit surging to ₹150.21 crores, marking a robust 15.00% quarter-on-quarter growth and an impressive 34.33% year-on-year expansion. The Hyderabad-based pharmaceutical manufacturer, with a market capitalisation of ₹14,024 crores, demonstrated exceptional operational momentum across all business verticals despite navigating a challenging global pharmaceutical environment.

Read full news article

Granules India Ltd Sees Technical Momentum Shift Amid Mixed Market Signals

2026-01-23 08:01:05

Granules India Ltd has experienced a notable shift in its technical momentum, moving from a mildly bearish to a mildly bullish trend as of late January 2026. Despite a recent downgrade in its Mojo Grade from Hold to Sell, the stock’s price action and key technical indicators suggest a nuanced outlook for investors navigating the Pharmaceuticals & Biotechnology sector.

Read full news article

Granules India Ltd Downgraded to Sell Amid Technical Weakness and Flat Financials

2026-01-22 08:05:29

Granules India Ltd, a key player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Hold to Sell as of 21 January 2026. This shift reflects a combination of deteriorating technical indicators, subdued financial trends, and valuation concerns, despite some strengths in management efficiency and debt servicing capability.

Read full news article

Granules India Ltd Faces Technical Momentum Shift Amid Bearish Signals

2026-01-22 08:00:52

Granules India Ltd has experienced a notable shift in its technical momentum, moving from a mildly bullish to a mildly bearish trend as of late January 2026. This change is underscored by a downgrade in its MarketsMOJO grade from Hold to Sell, reflecting growing concerns among analysts about the stock’s near-term price trajectory amid mixed technical indicator signals.

Read full news article

Why is Granules India Ltd falling/rising?

2026-01-17 00:45:09

Short-Term Price Movement and Market Performance

Granules India’s share price decline on 16-Jan was sharper than the broader market and its sector peers. The stock underperformed its sector by 1.86%, touching an intraday low of ₹576.80, representing a 3.77% drop during the trading session. The weighted average price indicates that a greater volume of shares traded closer to the day’s low, signalling selling pressure throughout the day. This price action suggests that investors were more inclined to offload shares rather than accumulate at higher levels.

Further compounding the downward pressure was the stock’s position relative to its moving averages. While the price remains above the 50-day, 100-day, and 200-day moving averages—indicating a generally positive medium t...

Read full news article

View All News